Editorial · 30 May 2025
Conference abstractPublished 31 Mar 2017
Construction, expression and characterization of a cancer-specific fusion protein targeting CD22 in B-cell malignancies
Shahid Beheshti University of Medical Sciences, Iran Pasteur Institute of Iran, Iran
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Dual-function proteins are a new class of therapeutics that composed of an antibody or antibody fragment linked to a cytotoxic molecule to facilitate the targeted delivery and destruction of malignant cells. CD22 is a highly internalizing B-cell specific surface antigen which overexpressed in 60%-80% of different types of B-cell malignancies. Therefore, anti-CD22 antibodies are ideal candidates for targeted intracellular delivery of antitumor agents. Apoptin is a small 13KDa protein which can induce apoptosis in tumor and transformed cells but not in normal cells. Hence, the apoptin protein can be used as a toxic moiety in development of cancer -specific fusion proteins. In this study, we generated a novel dual function protein by fusing apoptin to the C-terminus of a humanized anti CD-22 scFv; the anti-CD22 scFv portion of the protein targets the whole molecule to the tumors, while apoptin executes specific killing functions. Using the routine molecular methods, the recombinant anti-CD22 scFv-apoptin protein was expressed in E. coli and then purified. The in-vitro binding analyses by immunofluorescence and flow cytometry demonstrated that the anti-CD22 scFv specifically bind to Raji CD22 positive cells and almost not to Jurkat CD22 negative cells. Evaluation of apoptotic property of anti-CD22 scFv-apoptin using flow cytometry showed that following specific binding of anti-CD22 scFv-apoptin, the protein induced apoptosis significantly in Raji cells (p<0.05). In conclusion, we have successfully produced functional anti-CD22 scFv-apoptin in E.coli. This recombinant protein may offer a new opportunity for the treatment of CD22+ B-cell malignancies.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Biotechnology & Biomaterials.
Editorial · 30 May 2025
3D Bioprinting of Vascularized Tissue Constructs Using Bioink-Embedded Endothelial Cells
Editorial · 30 May 2025
Development of Flexible Bioelectronic Interfaces for Real-Time Neural Signal Monitoring
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Biotechnology & Biomaterials
- SubjectBiochemistry & Biotechnology
- SubjectMaterials Science
- BylineArticles whose byline prints “Solmaz Agha Amiri”
- BylineArticles whose byline prints “Najmeh Zarei”
- BylineArticles whose byline prints “Dorsa Khorasanizadeh”
- BylineArticles whose byline prints “Elahe Aminelahi”
- BylineArticles whose byline prints “Soraya Shahhosseini”
- BylineArticles whose byline prints “Vahid Khalaj”